ICAM1 and coronary artery disorder: The expression of ICAM-1 in the plaque of patients with CHD is significantly increased.18 Oral estrogen can reduce serum sICAM-1 to prevent the early process of atherosclerotic.19 A number of studies have confirmed that compared with the non-blood stasis syndrome group and healthy control group, the levels of hs-CRP, sICAM-1, sVCAM-1 in coronary blood stasis syndrome group are significantly increased.20-24